Eligible patients had COPD, were ages 40 or older, and were new initiators of these inhalers from 2021 to 2023. They were ...

AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive ...

The Hailie Smartinhaler device has also been cleared for use with inhalers from other ... to patients with asthma and COPD under a 510(k) over-the-counter clearance. In a statement, the company ...

CFC-free inhalers will not only protect the ozone, but also offer effective relief to the estimated 300 million people suffering from asthma and over 210 million suffering from COPD.